Medicine and Dentistry
Patient
77%
Melanoma
62%
Neoplasm
61%
Therapeutic Procedure
50%
B Cell
40%
Immune Checkpoint Inhibitor
26%
Malignant Neoplasm
25%
Cytotoxic T-Cell
22%
Marker
22%
Immunity
22%
Protein
20%
Mechanism of Action
20%
Krukenberg Tumor
20%
B Lymphocyte
20%
Triple Negative Breast Cancer
20%
Ovarian Cancer
20%
Ex Vivo
20%
Stimulation
20%
Secretion (Process)
20%
Monotherapy
18%
B-Cell Activating Factor
15%
T Cell
13%
Folate Receptor 1
11%
Overall Survival
10%
Immune-Related Adverse Events
8%
Pathogen
7%
Gene
7%
Therapeutics
6%
Immune Response
6%
Mortality
6%
Apolipoprotein
6%
Memory B Cell
6%
Programmed Death 1 Receptor
6%
Inflammation
6%
Experience
6%
Antibody Production
6%
Combination Therapy
5%
Tumor Regression
5%
Prognosis
5%
Clinical Management
5%
Clinical Study
5%
B Lymphocyte Receptor
5%
Immunology and Microbiology
B Cell
100%
Regulatory B Cells
20%
Regulatory T Cell
20%
B Cell Activating Factor
15%
Tumor Necrosis Factor
14%
Isotype
14%
Programmed Death-Ligand 1
12%
Humoral Immunity
9%
Memory B Cell
9%
Viral Disease
5%
Immunosuppression
5%
T Helper Cell
5%
Immune Escape
5%
Immune Checkpoint Blockade
5%
Blocking Antibody
5%
